hodgkin's lymphoma
Showing NaN - NaN of 7
Non-Hodgkin's Lymphoma, Hodgkin's Lymphoma, Myeloid Leukemia Trial in Detroit (Dasatinib, laboratory biomarker analysis)
Terminated
- Non-Hodgkin's Lymphoma
- +5 more
- Dasatinib
- laboratory biomarker analysis
-
Detroit, MichiganBarbara Ann Karmanos Cancer Institute
Dec 14, 2020
Non-Hodgkin's Lymphoma, Multiple, Mycosis Fungoides Trial in Detroit (Dasatinib)
Terminated
- Non-Hodgkin's Lymphoma
- +4 more
-
Detroit, MichiganBarbara Ann Karmanos Cancer Institute
Mar 12, 2020
Hodgkin's Lymphoma Trial in United States (TGR-1202 + brentuximab vedotin)
Completed
- Hodgkin's Lymphoma
- TGR-1202 + brentuximab vedotin
-
Duarte, California
- +3 more
Oct 1, 2019
Acute Leukemia, Chronic Myelogenous Leukemia, Myelodysplasia Trial in United States (Tacrolimus (ARM with Methotrexate),
Completed
- Acute Leukemia
- +8 more
- Tacrolimus (ARM with Methotrexate)
- +7 more
-
Duarte, California
- +29 more
Jan 2, 2019
Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, Acute Myelogenous Leukemia Trial in United States (VCL-CB01,
Completed
- Acute Lymphoblastic Leukemia
- +5 more
- VCL-CB01
- Phosphate-buffered Saline (PBS)
-
Tucson, Arizona
- +21 more
Jul 31, 2013